Septerna, Inc. (SEPN)
26.07
-1.31
(-4.78%)
USD |
NASDAQ |
Jan 16, 16:00
26.06
0.00 (0.00%)
After-Hours: 20:00
Septerna Shareholders Equity (Quarterly): 388.73M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 85.09M |
| Altimmune, Inc. | 185.60M |
| Arcturus Therapeutics Holdings, Inc. | 224.56M |
| Iovance Biotherapeutics, Inc. | 702.29M |
| Viking Therapeutics, Inc. | 713.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 606.65M |
| Total Liabilities (Quarterly) | 217.92M |
| Debt to Equity Ratio | 0.062 |
| Current Ratio | 6.531 |
| Net Debt Paydown Yield | -0.28% |